|
It was reported that a progav (#fv415t) was implanted during a procedure performed on (b)(6) 2020.(implantation date, according to questionnaire, is before production date) according to the complainant, the valve caused an overdrainage and had adjustment difficulties.The patient underwent a revision procedure on (b)(6) 2025.The complained product was sent to the manufacturer for investigation.No patient complications were reported as a result of the revision procedure.Same event as # 3004721439-2025-00037.
|
|
Visual inspection: during the investigation, scratches on the outer housing of the valve, but no significant deformation or damage was determined.Permeability test: a permeability test has shown that the valve is permeable.Computer controlled test: to investigate the claim of over- drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in the horizontal position.The results show that the valve opreates not within the acceptable tolerance in the horizontal position.An accelerated outflow of progav could be determined.Adjustment test: the progav 2.0 was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function is operational.However, the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valve, organic deposits were found in progav.Result: based on our investigation results, we can determine an accelerated outflow and non-adjustability at the progav.The visible deposits in the valve led to the functional impairment.Deposits of natural substances found in the body, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of proteins can affect the integrity of the valve.The examination of the return shipment is completed with the creation of this report.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|